Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop
RC Bast, JT Thigpen, SG Arbuck, K Basen-Engquist… - Gynecologic …, 2007 - Elsevier
OBJECTIVE: The unique characteristics of cancer, particularly issues involving the use of
surrogate endpoints in clinical trials, present special challenges in the development of …
surrogate endpoints in clinical trials, present special challenges in the development of …
New therapeutic agents in ovarian cancer
F Collinson, G Jayson - Current Opinion in Obstetrics and …, 2009 - journals.lww.com
Much further research is required to define if, when and how best to integrate these novel
therapies, and also to define associated biomarkers that predict toxicity and select patients …
therapies, and also to define associated biomarkers that predict toxicity and select patients …
Advanced ovarian cancer: what should be the standard of care?
BA Goff - Journal of gynecologic oncology, 2013 - synapse.koreamed.org
The standard treatment of advanced ovarian cancer is rapidly changing. As we begin to
understand that epithelial ovarian cancer is a heterogeneous disease, our treatment …
understand that epithelial ovarian cancer is a heterogeneous disease, our treatment …
The prognostic significance of anti-angiogenesis therapy in ovarian cancer: a meta-analysis
J Li, S Li, R Chen, H Yu, X Lu - Journal of ovarian research, 2015 - Springer
Objective The prognostic value of anti-angiogenesis therapy in ovarian cancer patients is
currently under debate. In this study, we assessed the effects of anti-angiogenesis therapy …
currently under debate. In this study, we assessed the effects of anti-angiogenesis therapy …
Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine
C Mei, W Gong, X Wang, Y Lv, Y Zhang… - Frontiers in …, 2023 - frontiersin.org
Ovarian cancer (OC) remains the most fatal disease of gynecologic malignant tumors.
Angiogenesis refers to the development of new vessels from pre-existing ones, which is …
Angiogenesis refers to the development of new vessels from pre-existing ones, which is …
Beyond chemotherapy: targeted therapies in ovarian cancer
TA Yap, CP Carden, SB Kaye - Nature Reviews Cancer, 2009 - nature.com
Ovarian cancer is the leading cause of death from gynaecological malignancies in the
Western world. Despite the evolution of surgical techniques and meticulously designed …
Western world. Despite the evolution of surgical techniques and meticulously designed …
Angiogenesis as a strategic target for ovarian cancer therapy
WA Spannuth, AK Sood, RL Coleman - Nature Clinical Practice …, 2008 - nature.com
Angiogenesis is a complex and highly regulated process that is crucial for tumor growth and
metastasis. Insights into the molecular mechanisms of tumor angiogenesis have led to the …
metastasis. Insights into the molecular mechanisms of tumor angiogenesis have led to the …
Current status of anti-angiogenic agents in the treatment of ovarian carcinoma
A Sánchez-Muñoz, E Pérez-Ruiz… - Clinical and …, 2009 - Springer
During the last decade we have assisted in the development of new therapeutic strategies
for the treatment of ovarian cancer, based on the best knowledge of molecular biology. One …
for the treatment of ovarian cancer, based on the best knowledge of molecular biology. One …
First-line treatment of advanced ovarian cancer: current research and perspectives
C Marchetti, C Pisano, G Facchini… - Expert review of …, 2010 - Taylor & Francis
Epithelial ovarian cancer is the fourth biggest cause of cancer-related death in women. Over
recent decades, improvements have been made in treatment outcome in terms of response …
recent decades, improvements have been made in treatment outcome in terms of response …
Ovarian cancer: beyond resistance
D Holmes - Nature, 2015 - nature.com
Ovarian cancer: beyond resistance | Nature Skip to main content Thank you for visiting
nature.com. You are using a browser version with limited support for CSS. To obtain the best …
nature.com. You are using a browser version with limited support for CSS. To obtain the best …